Valuation : Baxter International Inc.

Market Cap 13.35B 11.49B 10.81B 9.86B 18.41B 1,266B 18.5B 128B 49.48B 647B 50.13B 49.05B 2,053B P/E 2026 *
33.1x
P/E 2027 * 21.6x
Enterprise Value 20.25B 17.42B 16.39B 14.96B 27.91B 1,920B 28.06B 194B 75.04B 981B 76.02B 74.38B 3,113B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.66x
Free-Float
75.39%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day-3.76%
1 week-4.38%
Current month-4.38%
1 month-9.76%
3 months+28.28%
6 months+40.53%
Current year+30.09%
1 week 24.66
Extreme 24.66
26.12
1 month 24.66
Extreme 24.66
28.02
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer 57 2023-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

President, Front Line Care

-2,098 0.0004%
9/2/26 Tax

Chief Executive Officer

-54,276 0.0105%
9/1/26 Tax

President, CCS

-750 0.0001% -
Change 5-day change 1-year change 3-year change Capi.($)
-3.76%-4.38%+1.80%-36.21% 13.35B
-2.59%-4.39%-20.63%+4.82% 187B
-1.89%+1.92%-0.55%+15.59% 120B
-1.89%+0.34%+11.01%+82.23% 63.15B
-3.40%-5.18%+13.70%+44.83% 52.36B
-3.05%-4.79%-6.91%-32.94% 50.32B
-3.83%-7.17%+4.99%-19.43% 33.17B
-5.19%-0.97% - - 32.1B
-0.65%-0.99%+34.71%-16.37% 23.93B
-1.98%-7.53%-12.06%+6.09% 22.7B
Average -1.61%-0.76%+2.90%+5.40% 59.9B
Weighted average by Cap. -0.92%-0.78%-3.74%+12.85%

Financials

2026 *2027 *
Net sales 11.62B 9.99B 9.4B 8.58B 16.01B 1,101B 16.09B 111B 43.05B 563B 43.61B 42.67B 1,786B 11.86B 10.2B 9.6B 8.76B 16.35B 1,125B 16.44B 113B 43.96B 575B 44.53B 43.57B 1,824B
Net income 372M 320M 301M 275M 513M 35.27B 515M 3.56B 1.38B 18.03B 1.4B 1.37B 57.18B 687M 591M 556M 508M 948M 65.18B 952M 6.58B 2.55B 33.32B 2.58B 2.53B 106B
Net Debt 6.9B 5.93B 5.58B 5.09B 9.51B 654B 9.56B 65.98B 25.56B 334B 25.89B 25.33B 1,060B 6.32B 5.43B 5.11B 4.67B 8.71B 599B 8.75B 60.43B 23.41B 306B 23.71B 23.2B 971B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-09-08 US$24.86 -3.76% 5,907,297
26-09-04 US$25.83 +1.02% 3,415,196
26-09-03 US$25.57 -0.51% 4,699,471
26-09-02 US$25.70 +0.86% 4,167,853
26-09-01 US$25.48 -2.00% 5,275,633
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
24.86USD
Average target price
28.73USD
Spread / Average Target
+15.56%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!